New Delhi [India], October 25: In an effort to raise awareness and provide valuable insights into uro-oncology, Dr Anil Kumar T, a distinguished expert in the field, is sharing his expertise and recommendations. With a wealth of experience in treating urological cancers, Dr Anil Kumar T aims
According to the findings of a multicenter phase II clinical trial, treating people who have differentiated thyroid cancer (DTC), an advanced form of thyroid cancer that arises from thyroid follicular cells, with the targeted tyrosine kinase inhibitor (TKI) cediranib in addition to their tre
Treatment for over 80 per cent of breast cancer survivors does not end with surgery, radiation, and chemotherapy. Instead, doctors advise them to take medication to inhibit sex hormones, which can fuel tumour growth and cause recurrence, for the next five to ten years.
According to the findings of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Centre, adding an immunomodulatory agent to treatment with the targeted tyrosine kinase inhibitor (TKI) cediranib did not improve outcomes in patients with differ
Breast cancer is the most common disease in the European Union, accounting for 13.3 per cent of all new cancer cases in 2020. Breast cancer is expected to affect 1 in every 11 women in the EU by the age of 74.
Women with breast cancer will be enrolled in a clinical trial to investigate the ability of behavioural and psychological therapy to minimise the cardiac damage caused by anti-cancer medications. The unique CARDIOCARE initiative is being led by a coalition of European partners, including the
Some women with early-stage, low-risk breast cancer may not need radiotherapy after breast-conserving surgery, according to recent research from McMaster University, BC Cancer, Hamilton Health Sciences, and the University of British Columbia.
Patients with pancreatic cancer who took the benzodiazepine lorazepam (Ativan), commonly prescribed to treat anxiety during cancer treatment, had a shorter progression-free survival than patients who did not, according to the study.
Recent research done by McMaster University, BC Cancer, Hamilton Health Sciences, and the University of British Columbia suggests that some women with early-stage, low-risk breast cancer may not require radiotherapy after breast-conserving surgery
Mumbai (Maharashtra) [India], August 11: Arkade Group announced a unique initiative to give back to society. They have committed to contribute the cost of one square foot (sq. ft.) that they sell from their properties towards Tata Memorial Hospital (TMH), a premier institution that runs canc
Mumbai (Maharashtra) [India], August 4: The Helping Hands Foundation supports and helps children undergoing cancer treatment at the prestigious Tata Memorial Hospital. The foundation hosted their bi-annual fundraiser, The Rakhi Edit on 1st and 2nd August 2023 at the St. Regis Hotel, Mumbai.